Protalix BioTherapeutics, Inc.
Biotechnology company · Hackensack, New Jersey, United States · NYSE: PLX
Protalix BioTherapeutics, Inc. is a biotechnology company headquartered in Hackensack, New Jersey, United States. Its shares trade on NYSE under the ticker PLX.
Profile compiled from public records. Is this your company? Request a correction or update
Protalix BioTherapeutics at a glance
Typebiotechnology company
HeadquartersHackensack, New Jersey, United States
Stock listingNYSE: PLX
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1006281
Frequently asked questions about Protalix BioTherapeutics
Where is Protalix BioTherapeutics headquartered?
Protalix BioTherapeutics, Inc. is headquartered in Hackensack, New Jersey, United States.
What does Protalix BioTherapeutics do?
Protalix BioTherapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Protalix BioTherapeutics a public company?
Yes. Protalix BioTherapeutics, Inc. trades on NYSE under the ticker PLX.
Similar companies
- Royal Biologics, Inc.Hackensack, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences